CTSH — Cognizant Technology Solutions Corporation

The tape as of 2026-09-13 is a de-rating story, not an earnings-collapse story: CTSH is down ~28% YTD, yet the underlying numbers have been fine - Q2 2026 revenue of $5.48B came in at the high end (+4.5% y/y, +4.1% cc), adjusted EPS of $1.37 beat by ~3.9%, management raised FY26 adjusted EPS guidance, and trailing bookings reached $29.1B (+5% y/y). What is weighing on sentiment is the structural fear that generative AI compresses time-and-materials billings - shorter delivery windows, lower headcount-per-dollar - which is a multiple problem, not a quarter problem. Analyst consensus is a genuine Hold (22 buy / 24 hold / 5 sell), consensus PT $64.77 (~8% above the $60.00 price as of 2026-09-13) but the recent PT average is $58.83, below the current price, with a very wide $51-$82 dispersion. RSI at 52.31 and a 3-month return of +15.01% versus a 6-month return of -0.61% says the selling has stopped and the stock is basing, not that buyers have taken control.

Revenue has ground steadily higher over the 12 quarters in the data: $4.897B (Q3 2023) to $5.481B (Q2 2026), with YoY growth of +7.4% (Q3 2025), +4.9% (Q4 2025), +5.8% (Q1 2026), and +4.5% (Q2 2026) - a mild deceleration from the mid-single-to-high-single-digit pace, but stable, not deteriorating. Operating income has risen from $686M (Q3 2023) to $874M (Q2 2026). The important nuance is margin mix: gross margin has drifted down (FY2024 34.3% -> FY2025 33.1% -> 32.0% on a trailing-four-quarter basis; Q1 2026 gross margin was 29.6% versus 33.6% in Q1 2025), while operating margin held roughly flat at ~15.5-16.0% (FY2024 14.7% -> FY2025 16.1% -> 15.8% trailing). In plain English: delivery-level pricing is under pressure, and opex discipline (restructuring/Project Leap, delivery automation) is what is keeping the operating margin intact. That is a real caution flag, not a rounding error. EPS was $1.10-$1.39 in every quarter except Q3 2025's $0.56, where net income fell to $274M from ~$650M - a clear one-off charge, not a structural break, since the very next three quarters printed $1.34, $1.39, and $1.36. Cash generation is robust but lumpy and Q1-seasonal: trailing four-quarter free cash flow is $2.598B ($459M + $198M + $781M + $1,160M), well above FY2024's $1.971B, with Q1 consistently the weak quarter (FCF of $16M in Q1 2024, $323M in Q1 2025, $198M in Q1 2026). Finally, note the Q2 2026 balance sheet shift: long-term debt jumped from $535M to $1.527B while cash fell from $1.504B to $1.038B and equity dropped from $15.07B to $14.46B - consistent with a large debt-funded buyback, which flatters future EPS growth.

Cheap on every measure in the file, with one important adjustment. As of 2026-09-13, price is $60.00 against P/E TTM of 12.876 and 5-year average P/E of 17.59; P/S of 1.249 against a 5-year average of 1.97; P/B of 1.933; EV/EBITDA of 7.324; dividend yield of 2.25%; and trailing FCF yield of ~9.6% ($2.598B FCF / $27.0B market cap). Two of the headline ratios are artifacts, not signals: PEG of -2.436 and the depressed-looking TTM P/E both trace largely to the Q3 2025 one-off charge that cut that quarter's EPS to $0.56. Normalizing that quarter to ~$1.34 puts trailing EPS near $5.44 and the normalized trailing P/E at ~11.0x, versus ~10.4x forward on the FY26 guidance midpoint ($5.70-$5.82, consensus $5.752). The deterministic valuation-context overlay scores 89.6, labeling the stock 'Cheap vs. its own history' - and on the numbers that is correct: you are paying roughly 59% of the 5-year average P/E for a business still growing revenue ~4-5% with a 12.3% ROIC and a net-cash-ish balance sheet.

At $60.00 on 2026-09-13, the market is capitalizing FY26 guided EPS of $5.70-$5.82 at ~10.4x, versus a 5-year average trailing P/E of 17.59x. That gap is the entire debate. Either (a) the market is wrong and is applying a structurally impaired multiple to a business that will keep compounding mid-single-digit revenue with ~16% operating margins - in which case earnings are being delivered and the price simply hasn't caught up; or (b) the market is right and gen-AI deflation will pull revenue growth toward low single digits while compressing the ~16% operating margin, making 10x a fair-to-full multiple. The evidence as of this writing leans toward (a): guidance was raised, Q2 beat, bookings are still growing (+5% y/y), and Financial Services has posted two consecutive quarters of double-digit y/y growth. But the gross-margin slide (34.3% in FY24 to 32.0% trailing) is the tell that AI pricing pressure is already real at the delivery level, so this is a 'prove it every quarter' situation - if constant-currency growth drops below the bottom of the 4.0-5.5% guide, the multiple will not re-rate no matter how cheap the FCF yield looks.

As of 2026-09-13, RSI(14) stood at 52.31 - dead neutral, neither overbought nor oversold. Price at $60.00 was 2.19% below its 20-day SMA (implied ~$61.3), 11.08% above its 50-day SMA (implied ~$54.0), and 4.00% below its 200-day SMA (implied ~$62.5). That combination - price above a rising 50-day, below the 200-day, RSI mid-range, +15.01% over three months but -0.61% over six months and -3.71% in the last week - describes a post-downtrend base-building range, not a trend. Entry-timing implication: there is no urgency and no oversold bounce to buy. A decisive close above the ~$62.5 200-day would be the first real confirmation that the downtrend has broken; a loss of the ~$54.0 50-day would say the base is failing and the 52-week low of $37.08 is back in play.

• AI-driven pricing deflation in IT services: enterprise demand for gen-AI execution is high, but productivity gains shorten delivery windows and reduce time-and-materials billing - a direct structural threat to Cognizant's labor-arbitrage revenue model.
• Selective enterprise tech budgets: clients are funding AI programs partly by reallocating from run-the-business outsourcing spend, which caps growth in traditional managed-services contracts.
• Financial Services vertical concentration: CTSH's largest vertical has posted two straight quarters of double-digit y/y growth, but that makes the top line unusually sensitive to bank/finserv tech-budget cycles and rate-driven spending swings.
• Interest rates and defensive rotation: with a 0.83 beta and a 2.25% dividend yield, CTSH trades partly as a defensive value/income name; a falling rate environment would help the multiple, while continued rotation into AI infrastructure and semis keeps IT services as a source of funds.
• Delivery-cost and immigration/visa policy plus INR/USD currency exposure: wage inflation and visa cost changes flow straight into the gross margin line, which has already slipped from 34.3% (FY24) to 32.0% (trailing).

• Q3 2026 earnings on November 4, 2026 (before market open), with consensus EPS around $1.44 - the first real test of whether the raised FY26 guidance (4.0-5.5% cc revenue growth, $5.70-$5.82 adjusted EPS) holds.
• Continuation of the Financial Services double-digit growth streak and large-deal bookings (TTM $29.1B, +5% y/y) - proof that AI demand converts to billable revenue rather than just deflating price.
• Scaling of the AI talent base (Frontier Certified Engineer/Business Operator teams to 15,000, plus 1,500 U.S. college hires announced early September 2026) as a signal on whether Cognizant can monetize AI capability rather than be cannibalized by it.
• Continued debt-funded buybacks (long-term debt rose from $535M to $1.527B in Q2 2026 while equity fell $606M q/q) - mechanically accretive to EPS and a support for per-share value.
• Any evidence that the AI-deflation fear is overdone would drive multiple normalization toward the 5-year average P/E of 17.59x - the single largest potential source of return here.

• Structural AI deflation compressing both revenue growth (below the 4.0-5.5% cc guide) and the ~16% operating margin - the core bear case, and the reason a 10x forward multiple may be rational rather than cheap.
• Gross margin erosion already visible: 34.3% (FY24) to 33.1% (FY25) to 32.0% trailing, with Q1 2026 gross margin at 29.6% versus 33.6% a year earlier; opex cuts cannot offset delivery-level price pressure forever.
• Financial Services concentration - a slowdown in bank/finserv tech budgets would hit the strongest part of the portfolio hardest.
• Thinning balance-sheet cushion from buyback funding: cash down to $1.038B from $1.504B and long-term debt up to $1.527B from $535M in one quarter (still only 0.145 debt/equity, but the direction of travel matters).
• Lumpy, Q1-seasonal cash generation (Q1 2026 FCF $198M; Q1 2024 FCF just $16M) - a weak cash quarter could spook a market already primed to be skeptical.
• Persistent sentiment overhang: 5 sell ratings and a $51-$82 price-target spread mean the stock can stay cheap for a long time without a hard catalyst.

At $60.00 on 2026-09-13 this is a genuinely cheap, cash-generative, low-leverage business being priced as if its growth engine is structurally broken - and the reported numbers do not yet support that verdict: revenue +4.5% y/y, raised FY26 guidance, TTM free cash flow of $2.598B (a ~9.6% yield), 0.145 debt/equity, and a 2.25% dividend. My lean is positive on valuation, but I would not call it a slam dunk: gross margin is quietly eroding (34.3% -> 32.0%), the ~16% operating margin is being defended by cost cuts rather than pricing power, and the market's AI-deflation concern is legitimate rather than a sentiment mistake. Buy the cheapness with position sizing that respects the fact that if constant-currency growth breaks below 4%, the multiple is fair rather than cheap. (Analysis, not personalized financial advice.)

Blended two methods as of 2026-09-13: (1) 12.5x forward FY2026 adjusted EPS of $5.75 (company guidance $5.70-$5.82, consensus $5.752) = $71.9, a multiple set ~29% below the 5-year average trailing P/E of 17.59x to reflect slower ~5% revenue growth and genuine AI-deflation risk; (2) an 8.5% required FCF yield on $2.598B of trailing free cash flow gives $30.56B of equity value, or $67.9 per share on ~450M shares (market cap $27.03B / $60.00). The average of $71.9 and $67.9 is ~$70, which also sits inside my rough DCF check (3% FCF growth, 9.5-10% discount rate -> $72-$81), so I used $70.00.